177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas By Ogkologos - September 2, 2025 68 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Phase II study Source RELATED ARTICLESMORE FROM AUTHOR Significant PFS Improvement with Ibrutinib-Rituximab Compared to Immunochemotherapy in Previously Untreated Patients with Mantle Cell Lymphoma EMA Recommends a Change to the Terms of the Marketing Authorisation for Mosunetuzumab Combining Niraparib with Abiraterone Acetate and Prednisone Significantly Improves rPFS in Patients with mCSPC Harbouring BRCA1/2 or Other HRR Gene Alterations MOST POPULAR Utility of Prospective ctDNA Surveillance in Early TNBC and the Activity... December 5, 2022 How to Stay Connected When Your Partner Has Cancer May 11, 2022 Scanxiety September 15, 2021 ¿Puede el uso de un microondas causar cáncer? April 7, 2022 Load more HOT NEWS Activity and Safety of Atezolizumab Combined with Carboplatin and Pemetrexed in... An Updated Overview of Estimates for Cancer Incidence and Mortality in... Although Not Improving DFS, Adjuvant Avelumab May Potentially Reduce the Risk... Could food improve cancer treatment? – That Cancer Conversation
